HUGENASDAQHealthcare · Drug Manufacturers - Specialty & Generic

FSD Pharma Inc.

$0.09-10.10%($-0.01)

TickerSpark Score

52/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HUGE research report →

52-Week Range0% of range

Low $0.09

Current $0.09

High $109.19

Companywww.fsdpharma.com

FSD Pharma Inc. , through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease.

CEO: Zeeshan Saeed
IPO: 2018
Employees: 17
HQ: Toronto, ON, CA

Price Chart

-95.44% · this period

Valuation

Market Cap: $66.67K
P/E: -0.15
P/S: 0.00
P/B: 0.27
EV/EBITDA: 0.10
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -108.36%
ROIC: -192.35%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-18,564,915 · 20.40%
EPS: $-0.47 · 21.67%
Op Income: $-19,929,008
FCF YoY: 62.27%

Performance & Tape

52W High: $109.19
52W Low: $0.09
50D MA: $8.13
200D MA: $36.69
Beta: 0.85
Avg Volume: 196.16K

Get TickerSpark's AI analysis on HUGE

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime